Discuss main objectives for the conference.
Discuss corporate compliance and the role of the OL.
Identify how the regulatory landscape will impact MSL practices and OL engagement (especially the Sunshine Act).
Identify best practices for industry to communicate compliance with healthcare providers to avoid fines and penalties.
Define objectives and the roles and responsibilities of medical affairs and sales/marketing teams.
Identify the impact - both positive and negative - on the exchange of scientific information and what can be done to improve processes.
Explain how to establish criteria of how to define an OL and identify emerging leaders.
Discuss how to improve industry image and influence OL attitudes.
Discuss global, national, regional, and up-and-coming KOL's.
Identify and align KOLs according to specific target audience needs.
Discuss what opinion leaders value from the medical relationship.
Identify opinion leaders' expectations of the Medical Science Liaison.
Discuss how conflicts of interest are managed in these relationships.
Identify innovations in engagement.
Discuss advanced guidlines, including access fees, licensure and privacy training related to the operation of feild-based medical teams under the new requirements.
Discuss guidence around antikickback statutes and government enforcement affecting OL engagement.
Identify advantages of building a KOL program from the inside out.
List common definitions for KOLs.
Identify the importance of a KOL segmentation model.
Explain how Acorda Therapeutics is successfully integrating its MSL team with clinical operations to advance the site selection and patient recruitment of company-sponsored trials.
Identify best practices to assess site, determine if it's a valid and effective location, evaluate recruitment challenges and gain feedback about the study.
Discuss topics learned on day one.
Discuss the use of Ad Boards during clinical/drug development and post - marketing.
Explain how to choose the size and makeup of the board.
Discuss the use of virtual Ad Boards.
Identify customer/KOL selection qualifications.
Discuss appropriate thought leaders for scientific goals.
Create a clear understanding of OL medical expertise to influence physician development.
Identify possible skill development steps MSLs must take to advance their careers, inculding considerations for certification criteria, risk of individual liability and selectivity of OLs.
Identify beginner MSL early career hurdles.
Identify the benefits of an ISS program and the role of the MSL.
Discuss the responsibilities of the Sponsor Investigator and the company as defined in the regulations.
Discuss considerations for metrics, payment negotiation/execution and fair market value assessments.
Identify the role of international MSLs and how they interact with KOLs.
Discuss how to encourage MSL leaders in various countires to include the MSL role in overall thought leader plan.
Explain ways to entrench the MSL within the global organization.
Identify how to bring value to your OL relationships and maintain current relationships.
Discuss a high level overview of industry landscape.
Identify keys to KOL engagement in the program.
Discuss challenges of working with other internal departments and ultimately propose a solution on how to better align activities to enhance cross-functional communication.
Discuss whether or not in-house counterparts are effectively communicating with MSLs and if they need to give MSLs more content to work with when engaging OLs.
Discuss whether or not MSLs are providing in-house professionals the information they need, if MSLs are clearly communicating their finding and if there is a need for information/knowledge retention.
Explain how to improve cross-functional internal communication.
Identify the needs of stakeholders in various departments.
Discuss how to transfer field-based infromation back to upper management to affect decision making.
Identify opinion leaders using primary and secondary research techniques.
Discuss how to connect leaders and learners to increase impact, participation, recall and overall value.
What questions have arisen in your practice for which you need answers/strategies that you can implement?
Are you interested in basic, intermediate or advanced level trainings?
What barriers might you have that would interfere with implementation of new information learned from this training?
How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?
Additional comments:
